Tylenol/Ibuprofen vs Oral Steroids for Musculoskeletal Pain

(MOTION Trial)

This trial explores the effectiveness of two treatments for short-term relief of acute musculoskeletal (MSK) pain, which is sudden pain in muscles, bones, or joints. One group of participants will receive a steroid medication called Methylprednisolone, while the other group will take a combination of Acetaminophen (Tylenol) and Ibuprofen (Motrin). The goal is to determine which treatment provides better pain relief. Adults who have experienced sudden MSK pain for less than two weeks and can speak English may be suitable for this study. As a Phase 4 trial, the treatments are already FDA-approved and proven effective, and this research aims to understand how they benefit more patients.

The trial requires that you stop taking certain medications, such as anti-platelet agents, oral anti-coagulants, daily prednisone, and chronic pain medications like gabapentin, Lyrica, or narcotics.

Research shows that acetaminophen and ibuprofen are generally safe when taken as directed. Acetaminophen is commonly used and considered very safe up to 4 grams per day. Studies indicate that combining ibuprofen and acetaminophen can provide pain relief similar to or better than other pain medications, including opioids, without increasing side effects.

Methylprednisolone, a type of steroid, has been used safely in various treatments and effectively reduces pain. However, long-term steroid use can lead to side effects like weaker bones (osteoporosis) and other muscle and bone issues. These side effects are less common with short-term use, such as the six-day treatment in this trial.

Researchers are excited about these treatments for musculoskeletal pain because they offer two distinct approaches. The combination of acetaminophen and ibuprofen, both well-known pain relievers, is being tested together to see if their combined effect offers enhanced pain relief compared to when used separately. Meanwhile, the use of methylprednisolone, an oral steroid, is being explored for its anti-inflammatory properties, which might provide quicker and more substantial relief by directly reducing inflammation, unlike standard over-the-counter pain meds. By comparing these two methods, researchers hope to identify a more effective and faster-acting pain management strategy.

This trial will compare the effectiveness of methylprednisolone with a combination of acetaminophen and ibuprofen for musculoskeletal pain. Research has shown that methylprednisolone, a type of steroid, can reduce pain and improve mobility. In one study, patients experienced more pain relief than those who took a placebo, which contains no active medicine. Another study found that injections of methylprednisolone reduced hand pain, with effects lasting up to 12 weeks.